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families (Figure). The MLVA type 
was determined in 1 contact; it also 
was MLVA type J, suggesting that 
carriage in this contact was related to 
spread of the same clone. Of interest, 
none of these 3 household members 
had respiratory symptoms. Nilsson et 
al. (10) also reported a high frequency 
of  M. pneumoniae DNA carriage 
in household contacts; however, in 
contrast to contacts in our study, all 
of the household contacts in the study 
by Nilsson et al. had ongoing or recent 
respiratory tract symptoms. 
In summary, we report an 
outbreak of M. pneumoniae infections 
conﬁ  rmed by MLVA, a discriminatory 
typing method. MLVA typing revealed 
the clonal spread of a single M. 
pneumoniae type J strain in children 
attending the same primary school 
and in their household contacts. The 
cases we identiﬁ  ed may represent only 
a small proportion of the actual cases, 
which were likely underestimated due 
to mild symptoms, poor knowledge 
of  M. pneumoniae infections by 
general practitioners, and lack of PCR 
availability. We showed that MLVA 
typing of M. pneumoniae can be used 
to detect clonal spread and outbreaks. 
This approach might also be useful for 
studying the worldwide emergence of 
M. pneumoniae macrolide resistance 
and for ﬁ  nding resistant clones with 
the potential for spreading.
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Risk for Emergence 
of Dengue and 
Chikungunya Virus 
in Israel
To the Editor: In recent years, 
Aedes albopictus, a mosquito vector 
of dengue and chikungunya viruses, 
has rapidly expanded in Europe. Since 
2007, the presence of viremic patients 
with imported cases of dengue and 
chikungunya virus infection has 
resulted in several incidences of 
autochthonous transmission of the 
viruses in Italy, France, and Croatia 
(1–4).
A. albopictus mosquitoes have 
invaded Israel since 2002. A recent 
national survey showed wide 
distribution of the mosquito in Israel 
(5), and dengue and chikungunya 
virus infection are increasingly 
reported in travelers from Israel 
who return home from trips to other 
countries (6,7). We looked for overlap 
between the distribution areas of A. 
albopictus mosquitoes in Israel and 
the living areas of travelers who have 
returned to Israel with acute dengue 
or chikungunya virus infections. 
We discuss the possibility of 
autochthonous transmission of these 
viruses in Israel.
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All cases of imported, sero-
logically proven acute dengue 
and chikungunya virus infection 
registered during 2008–2010 at the 
National Center for Zoonotic Viruses, 
Central Virological Laboratory, Israel 
Ministry of Health, were included in 
the study. For dengue diagnosis, IgM 
capture ELISA was run in parallel with 
dengue indirect IgG ELISA, according 
to the manufacturer’s (PANBIO, 
Brisbane, Australia) instructions. For 
chikungunya diagnosis, microchip 
technology (Euroimmune, Gross-
Groenau, Germany) was performed to 
detect speciﬁ  c IgM and IgG antibodies. 
Paired acute- and convalescent-phase 
samples with a >4-fold increase 
conﬁ  rmed an acute case.
Laboratory diagnosis was 
matched to clinical observations; 
travel history, along with previous 
vaccination for yellow fever; and 
tickborne or Japanese encephalitis. 
Local infection was differentiated 
from imported infection by 
interpretation of a questionnaire that 
is required from treating physicians 
before serologic testing. Testing for 
West Nile virus and Sindbis virus were 
done to rule out cross-reactions with 
endemic ﬂ  aviviruses and alphaviruses, 
respectively.
Geographic distribution of A. 
albopictus mosquitoes in Israel 
during 2008–2009 was observed by 
monitoring the presence of eggs, 
larvae, and adult mosquitoes in ovitraps 
and by monitoring reports from 
municipalities and pest management 
professionals (5). Patients’ areas or 
municipalities of residence were 
plotted on a map describing the 
currently known distribution of A. 
albopictus mosquitoes in Israel. We 
evaluated the number and proportion 
of dengue and chikungunya patients in 
A. albopictus–endemic regions.
During the study years, 41 and 
15 patients, respectively, received 
diagnoses of dengue and chikungunya 
virus infection at the National Center 
for Zoonotic Viruses (Figure). Of 
the 41 dengue and 15 chikungunya 
patients, 27 (66%) and 12 (80%), 
respectively, lived in areas where A. 
albopictus mosquitoes were endemic 
(Figure). No autochthonous cases 
were reported.
The establishment of A. 
albopictus mosquitoes in Israel 
provides suitable conditions for 
autochthonous transmission of dengue 
and chikungunya viruses. Although it 
was traditionally regarded a secondary 
vector for dengue virus, A. albopictus 
can spread the virus. The potential 
risk for local outbreaks of dengue 
or chikungunya virus disease is 
dependent on the presence of viremic 
patients and a suitable vector (8). 
Recent reports emphasized the risk for 
autochthonous transmission of dengue, 
yellow fever, and chikungunya viruses 
in Europe. This risk is strengthened by 
the history of yellow fever and dengue 
in temperate regions. Dengue virus 
transmission may follow 2 general 
patterns: epidemic and hyperendemic 
dengue. Epidemic dengue 
transmission may occur as an isolated 
event when virus is introduced into a 
region with susceptible hosts and an 
adequate vector. Such events involve 
a single virus strain and may manifest 
in explosive transmission.
Reported cases of autochthonous 
dengue in France and Croatia were 
presumed to be related to newly 
spread A. albopictus mosquitoes (2–
4). An outbreak of chikungunya virus 
infections that occurred in Italy during 
the summer of 2007 involved >200 
persons (1).  A. albopictus mosquito 
spread in Hawaii was regarded as the 
cause of a dengue outbreak in 2001 
(9), and in Florida, dengue fever was 
recently documented in Key West, 
where  A. aegypti mosquitoes are 
established (10).
In this report, we document 
importation of dengue and 
chikungunya viruses by travelers 
to  A. albopictus–endemic areas in 
Israel. We show that most patients 
in Israel with imported dengue and 
chikungunya virus infection reside 
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Figure. Patients with imported 
dengue (black circles) or 
chikungunya (black triangles) 
virus infection living in Aedes 
albopictus–endemic areas 
of Israel, 2008–2010. Gray 
shading indicates known and 
black outline suspected A. 
albopictus–endemic areas. 
Of the patients with dengue 
and chikungunya virus 
disease, 66% (27/41) and 
80% (12/15), respectively, 
lived in A. albopictus–
endemic areas.LETTERS
in  A. albopictus–endemic areas of 
the country. The reported number of 
serologically proven cases probably 
underestimates the true extent of the 
diseases in Israeli travelers because 
underdiagnosis and underreporting 
are common. Both dengue and 
chikungunya virus infection result in 
viremia that may last up to 5 days, 
and viremic patients living in A. 
albopictus–endemic areas put the area 
population at risk for infection.
In summary, we report conditions 
in Israel suitable for autochthonous 
transmission of dengue and 
chikungunya viruses. Although 
no autochthonous cases have been 
reported in Israel, they have been 
reported from other countries where 
A. albopictus mosquitoes are newly 
endemic. In Israel and other areas 
where this species is newly endemic, 
both dengue and chikungunya virus 
infection should be considered in the 
differential diagnosis of acute febrile 
illnesses, even when the patients do 
not report recent travel to tropical 
areas. Enhanced surveillance may be 
needed to prevent epidemic spread 
of these diseases. Consideration 
must be taken to isolating suspected 
(viremic) dengue and chikungunya 
patients to prevent the establishment 
of autochthonous transmission.
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Possible 
Pet-associated 
Baylisascariasis 
in Child, Canada
To the Editor:  Baylisascaris 
procyonis, a roundworm parasite 
of raccoons (Procyon lotor), 
increasingly is being documented as 
a cause of severe human disease (1). 
Approximately 130 species of wild 
and domesticated animals have been 
affected with B. procyonis neural 
larva migrans, and the parasite is 
increasingly recognized as a cause of 
human encephalitis (2; K. Kazacos, 
unpub. data). The ﬁ  rst  recognized 
human case was reported in 1984 in a 
10-month-old child in Pennsylvania, 
USA (3). Since then, ≈30 additional 
cases of severe or fatal B. procyonis 
encephalitis have been reported in 
the United States (4–7; K. Kazacos, 
pers. comm.). To our knowledge, 
only 1 account of human B. procyonis 
infection has been reported in Canada 
(in 2009) (8). We report another case 
of human B. procyonis infection 
in Canada, indicating its probable 
transmission from peridomestic 
raccoons.
In 2008, a 14-month-old 
previously healthy boy in Hamilton, 
Ontario, Canada, sought care for 
fever, regression in speech for 5 days, 
and failure to bear weight for 2 days. 
His parents also noticed that he was 
not tracking with his eyes. Caregivers 
recalled a macular rash on the face 
and trunk that had faded over time. 
The child was hospitalized, and a 
workup for encephalitis was initiated. 
He was hemodynamically stable and 
had ﬂ  accid tone, with inability to bear 
weight. No visible rashes were found. A 
fundoscopic examination indicated no 
evidence of unilateral chorioretinitis. 
The child was unable to track objects, 
which suggested vision loss in both 
eyes. Blood cultures, urine cultures, 
and lumbar puncture were performed. 
Results of blood analyses showed the 
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